Tongue Cancer Patients Can be Distinguished from Healthy Controls by Specific <i>N</i>‐Glycopeptides Found in Serum

Abstract

The authors are the first to suggest specific N-glycopeptides to serve as potential serum biomarkers to detect preclinical OSCC in patients. These N-glycopeptides are the lead candidates for validation as future diagnostic modalities of OSCC as early as stage I.